CSPHF
Price
$1.00
Change
+$0.14 (+16.28%)
Updated
Sep 23 closing price
Capitalization
987.66M
Intraday BUY SELL Signals
SIGY
Price
$0.75
Change
-$1.30 (-63.41%)
Updated
Feb 3 closing price
Capitalization
1.2M
Intraday BUY SELL Signals
Interact to see
Advertisement

CSPHF vs SIGY

Header iconCSPHF vs SIGY Comparison
Open Charts CSPHF vs SIGYBanner chart's image
CSTONE PHARMACEUTICALS
Price$1.00
Change+$0.14 (+16.28%)
Volume$150
Capitalization987.66M
Sigyn Therapeutics
Price$0.75
Change-$1.30 (-63.41%)
Volume$2K
Capitalization1.2M
CSPHF vs SIGY Comparison Chart in %
CSPHF
Daily Signal:
Gain/Loss:
SIGY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CSPHF vs. SIGY commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Hold and SIGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CSPHF: $0.72 vs. SIGY: $0.75)
Brand notoriety: CSPHF and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 600% vs. SIGY: 88%
Market capitalization -- CSPHF: $987.66M vs. SIGY: $1.2M
CSPHF [@Biotechnology] is valued at $987.66M. SIGY’s [@Biotechnology] market capitalization is $1.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, CSPHF is a better buy in the long-term than SIGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSPHF’s TA Score shows that 2 TA indicator(s) are bullish while SIGY’s TA Score has 4 bullish TA indicator(s).

  • CSPHF’s TA Score: 2 bullish, 4 bearish.
  • SIGY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SIGY is a better buy in the short-term than CSPHF.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while SIGY (@Biotechnology) price change was +15.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPHF($988M) has a higher market cap than SIGY($1.2M). CSPHF YTD gains are higher at: -19.474 vs. SIGY (-56.144).
CSPHFSIGYCSPHF / SIGY
Capitalization988M1.2M82,060%
EBITDAN/A-2.67M-
Gain YTD-19.474-56.14435%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A85.6K-
Total DebtN/A2.81M-
FUNDAMENTALS RATINGS
SIGY: Fundamental Ratings
SIGY
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSPHFSIGY
RSI
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
37%
Bullish Trend 2 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
31%
Bullish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
30%
Bullish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
28%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CSPHF
Daily Signal:
Gain/Loss:
SIGY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMIX46.420.30
+0.65%
Columbia Small Cap Value Discv A
HSMTX13.830.01
+0.07%
Hartford Small Cap Value R5
NBGAX54.67-0.29
-0.53%
Neuberger Genesis Adv
PLIEX31.95-0.56
-1.72%
Plumb Equity Institutional
WVALX41.50-1.13
-2.65%
Weitz Large Cap Equity-Investor Cl

CSPHF and

Correlation & Price change

A.I.dvisor tells us that CSPHF and BCAB have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSPHF and BCAB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
BCAB - CSPHF
9%
Poorly correlated
+9.06%
SIGY - CSPHF
8%
Poorly correlated
+21.95%
NBTX - CSPHF
7%
Poorly correlated
+0.33%
HYFT - CSPHF
5%
Poorly correlated
-3.09%
ABCL - CSPHF
3%
Poorly correlated
+0.57%
More

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
+21.95%
OTLK - SIGY
23%
Poorly correlated
-2.27%
ACHV - SIGY
21%
Poorly correlated
-2.56%
KALA - SIGY
21%
Poorly correlated
-10.84%
CSPHF - SIGY
8%
Poorly correlated
N/A
CPMV - SIGY
6%
Poorly correlated
+0.40%
More